A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
מצבים רפואיים
Relapsed/Refractory Systemic Light Chain Amyloidosis
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
City of Hope, Duarte, California, United States
Colorado Blood Cancer Institute/SCRI, Denver, Colorado, United States
Boston Medical Center, Boston, Massachusetts, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
Ohio State University, Columbus, Ohio, United States
SCRI Oncology Partners, Nashville, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
National and Kapodistrian University of Athens, Athens, Greece
Seoul National University Hospital, Seoul, South Korea
Asan Medical Center, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
Seoul St. Mary's Hospital - The Catholic University of Korea, Seoul, South Korea
Hospital Universitari Son Espases, Palma, Balearic Islands, Spain
Clinica Universidad de Navarra - Pamplona, Pamplona, Navarre, Spain
Hospital de Cabuenes, Gijón, Principality of Asturias, Spain
Universität de Barcelona- Institut d' Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
University Hospital La Fe, Valencia, Spain
University College London Hospitals, London, United Kingdom
The Christie NHS Foundation Trust, Manchester, United Kingdom
מובילי המחקר
Clinical Trial Management
Study Director
Regeneron Pharmaceuticals